NIH-funded research R01 grant

Inflammatory and Genetic Heart Disease: Using Metabolic Clues to Guide Diagnosis and Therapy

Official title: Inflammatory and Genetic Cardiomyopathies: Metabolic Phenotyping to Guide Diagnosis and Therapy

Funded at University of Washington · NIH-11378198 · Data updated 2026-11-12

Aims to improve diagnosis and treatment decisions for people with complex heart muscle diseases by combining metabolic data, genetics, and advanced imaging.

More Cardiomyopathies research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Washington
NIH-funded
Lab location1 site (Seattle, United States)
Project startAugust 15, 2025
Project endMay 31, 2029
Funding year2026
Award (this year)$675,763
NIH project number5R01HL172820-02
Project IDNIH-11378198 on NIH RePORTER

Who could benefit from this research

Could help

Adults with suspected cardiac sarcoidosis, genetic cardiomyopathies, or idiopathic 18FDG-avidity who may benefit from combined metabolic, imaging, and genetic evaluation.

Less likely to help

Patients with clearly defined, unrelated heart conditions or those unable to undergo PET imaging or genetic testing.

What this research studies

This project will enroll patients who may have cardiac inflammatory or genetic cardiomyopathies and use PET imaging, genetic testing, and metabolic studies to better distinguish between conditions. Researchers will also apply voltage-guided endomyocardial biopsy with enhanced tissue analysis to learn how these diseases manifest and respond to treatment. The goal is to create a practical approach that helps doctors decide when genetic testing or PET scans are needed and to develop less invasive tests to explain abnormal heart signals. By turning bedside observations into lab insights, the study seeks to tailor therapies to individual patients and prevent unnecessary treatments.

Why it matters

Potential benefit: If successful, patients could receive more accurate diagnoses and personalized treatment plans that avoid unnecessary therapies.

How similar studies have gone: Previous work suggests that integrating imaging and genetics can reveal misdiagnosed cases and guide therapy, with ongoing exploration in this area.

Where this research is happening

  • University of Washington
    Seattle, United States
    Active

Researchers

  • Principal investigator: Nazer, Babak — University of Washington
  • Study coordinator: Nazer, Babak

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.